186 related articles for article (PubMed ID: 20890087)
1. Suppression of Aurora-A oncogenic potential by c-Myc downregulation.
Yang S; He S; Zhou X; Liu M; Zhu H; Wang Y; Zhang W; Yan S; Quan L; Bai J; Xu N
Exp Mol Med; 2010 Nov; 42(11):759-67. PubMed ID: 20890087
[TBL] [Abstract][Full Text] [Related]
2. Aurora kinases A and B are up-regulated by Myc and are essential for maintenance of the malignant state.
den Hollander J; Rimpi S; Doherty JR; Rudelius M; Buck A; Hoellein A; Kremer M; Graf N; Scheerer M; Hall MA; Goga A; von Bubnoff N; Duyster J; Peschel C; Cleveland JL; Nilsson JA; Keller U
Blood; 2010 Sep; 116(9):1498-505. PubMed ID: 20519624
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of Aurora-A kinase promotes tumor cell proliferation and inhibits apoptosis in esophageal squamous cell carcinoma cell line.
Wang XX; Liu R; Jin SQ; Fan FY; Zhan QM
Cell Res; 2006 Apr; 16(4):356-66. PubMed ID: 16617331
[TBL] [Abstract][Full Text] [Related]
4. Interaction between survivin and aurora-B kinase plays an important role in survivin-mediated up-regulation of human telomerase reverse transcriptase expression.
Furuya M; Tsuji N; Kobayashi D; Watanabe N
Int J Oncol; 2009 Apr; 34(4):1061-8. PubMed ID: 19287963
[TBL] [Abstract][Full Text] [Related]
5. Widespread genomic instability mediated by a pathway involving glycoprotein Ib alpha and Aurora B kinase.
Li Y; Xu FL; Lu J; Saunders WS; Prochownik EV
J Biol Chem; 2010 Apr; 285(17):13183-92. PubMed ID: 20157117
[TBL] [Abstract][Full Text] [Related]
6. DCLK1 inhibition attenuates tumorigenesis and improves chemosensitivity in esophageal squamous cell carcinoma by inhibiting β-catenin/c-Myc signaling.
Zhang L; Zhou S; Guo E; Chen X; Yang J; Li X
Pflugers Arch; 2020 Aug; 472(8):1041-1049. PubMed ID: 32533239
[TBL] [Abstract][Full Text] [Related]
7. Regulation of the Aurora-A gene following topoisomerase I inhibition: implication of the Myc transcription factor.
Courapied S; Cherier J; Vigneron A; Troadec MB; Giraud S; Valo I; Prigent C; Gamelin E; Coqueret O; Barré B
Mol Cancer; 2010 Aug; 9():205. PubMed ID: 20682043
[TBL] [Abstract][Full Text] [Related]
8. An integrated genomic approach to identify predictive biomarkers of response to the aurora kinase inhibitor PF-03814735.
Hook KE; Garza SJ; Lira ME; Ching KA; Lee NV; Cao J; Yuan J; Ye J; Ozeck M; Shi ST; Zheng X; Rejto PA; Kan JL; Christensen JG; Pavlicek A
Mol Cancer Ther; 2012 Mar; 11(3):710-9. PubMed ID: 22222631
[TBL] [Abstract][Full Text] [Related]
9. Aurora B hyperactivation by Bub1 overexpression promotes chromosome missegregation.
Ricke RM; van Deursen JM
Cell Cycle; 2011 Nov; 10(21):3645-51. PubMed ID: 22033440
[TBL] [Abstract][Full Text] [Related]
10. [The function of Aurora A and its role in the development of liver cancer].
Li M; Ren ZG
Zhonghua Gan Zang Bing Za Zhi; 2017 Jun; 25(6):477-480. PubMed ID: 28763871
[TBL] [Abstract][Full Text] [Related]
11. Stabilization of N-Myc is a critical function of Aurora A in human neuroblastoma.
Otto T; Horn S; Brockmann M; Eilers U; Schüttrumpf L; Popov N; Kenney AM; Schulte JH; Beijersbergen R; Christiansen H; Berwanger B; Eilers M
Cancer Cell; 2009 Jan; 15(1):67-78. PubMed ID: 19111882
[TBL] [Abstract][Full Text] [Related]
12. Pim1 promotes human prostate cancer cell tumorigenicity and c-MYC transcriptional activity.
Kim J; Roh M; Abdulkadir SA
BMC Cancer; 2010 Jun; 10():248. PubMed ID: 20515470
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic potential of a synthetic lethal interaction between the MYC proto-oncogene and inhibition of aurora-B kinase.
Yang D; Liu H; Goga A; Kim S; Yuneva M; Bishop JM
Proc Natl Acad Sci U S A; 2010 Aug; 107(31):13836-41. PubMed ID: 20643922
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous Aurora-A/STK15 overexpression and centrosome amplification induce chromosomal instability in tumour cells with a MIN phenotype.
Lentini L; Amato A; Schillaci T; Di Leonardo A
BMC Cancer; 2007 Nov; 7():212. PubMed ID: 17999753
[TBL] [Abstract][Full Text] [Related]
15. Stable knockdown of Aurora-A by vector-based RNA interference in human esophageal squamous cell carcinoma cell line inhibits tumor cell proliferation, invasion and enhances apoptosis.
Wang X; Dong L; Xie J; Tong T; Zhan Q
Cancer Biol Ther; 2009 Oct; 8(19):1852-9. PubMed ID: 19770595
[TBL] [Abstract][Full Text] [Related]
16. Targeting Aurora-2 kinase in cancer.
Warner SL; Bearss DJ; Han H; Von Hoff DD
Mol Cancer Ther; 2003 Jun; 2(6):589-95. PubMed ID: 12813139
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of active Aurora-C kinase results in cell transformation and tumour formation.
Khan J; Ezan F; Crémet JY; Fautrel A; Gilot D; Lambert M; Benaud C; Troadec MB; Prigent C
PLoS One; 2011; 6(10):e26512. PubMed ID: 22046298
[TBL] [Abstract][Full Text] [Related]
18. The histone deacetylase SIRT2 stabilizes Myc oncoproteins.
Liu PY; Xu N; Malyukova A; Scarlett CJ; Sun YT; Zhang XD; Ling D; Su SP; Nelson C; Chang DK; Koach J; Tee AE; Haber M; Norris MD; Toon C; Rooman I; Xue C; Cheung BB; Kumar S; Marshall GM; Biankin AV; Liu T
Cell Death Differ; 2013 Mar; 20(3):503-14. PubMed ID: 23175188
[TBL] [Abstract][Full Text] [Related]
19. Oncogenic role of nuclear accumulated Aurora-A.
Tatsuka M; Sato S; Kanda A; Miki T; Kamata N; Kitajima S; Kudo Y; Takata T
Mol Carcinog; 2009 Sep; 48(9):810-20. PubMed ID: 19204928
[TBL] [Abstract][Full Text] [Related]
20. PDK1 signaling toward PLK1-MYC activation confers oncogenic transformation, tumor-initiating cell activation, and resistance to mTOR-targeted therapy.
Tan J; Li Z; Lee PL; Guan P; Aau MY; Lee ST; Feng M; Lim CZ; Lee EY; Wee ZN; Lim YC; Karuturi RK; Yu Q
Cancer Discov; 2013 Oct; 3(10):1156-71. PubMed ID: 23887393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
